XBiotech Owners | StatInvestor

Health Care & Life Sciences » Biotechnology | XBiotech Inc.

XBiotech Inc. | Ownership

Companies that own XBiotech Inc.

Name

Shares Held

% Shares Out

Change In Shares

% of Assets

As of Date

The Vanguard Group, Inc.

785,658

2.21%

302

06/30/2018

Millennium Management LLC

207,768

0.59%

207,768

06/30/2018

Geode Capital Management LLC

127,077

0.36%

-42,729

06/30/2018

Ergoteles LLC

89,025

0.25%

73,652

0.02%

06/30/2018

BlackRock Fund Advisors

81,713

0.23%

-753,461

06/30/2018

Element Capital Management LLC

73,526

0.21%

73,526

0.01%

06/30/2018

Charles Schwab Investment Management, Inc.

50,476

0.14%

-37,633

06/30/2018

Credit Suisse Securities (USA) LLC (Broker)

48,217

0.14%

-6,620

06/30/2018

Northern Trust Investments, Inc.

44,893

0.13%

-169,733

06/30/2018

Dimensional Fund Advisors LP

37,610

0.11%

06/30/2018

About XBiotech

View Profile

Address	5217 Winnebago Lane Austin Texas 78744 United States
Employees	-
Website	http://www.xbiotech.com
Updated	07/08/2019
XBiotech, Inc. is a biopharmaceutical company, which engages in discovering and developing True Human monoclonal antibodies for treating diseases. It offers MABp1, which targets and neutralizes interleukin-1 alpha, a molecule known to promote angiogenesis, growth and spread of tumors, as well as mediate symptoms such as metabolic dysregulation, fatigue, and anxiety associated with advanced cancer. The company was founded by John Simard on March 22, 2005 and is headquartered in Austin, TX.